Navigation Links
Bright Light Therapy via Ear Canals Improved Reaction Times of Top Athletes in a Placebo-Controlled Psycho-Motoric Study
Date:12/14/2011

HELSINKI, December 14, 2011 /PRNewswire/ --

A placebo controlled study involving top ice hockey players from the Finnish national league has shown motoric reaction times reduced by one fifth in players using the Valkee bright light headset. In the treatment group, the athletes were given 12 minutes of bright light via the ear canal each morning for three weeks. The study was conducted by the Department of Exercise and Medical Physiology at Verve Research, Finland.

Motoric reaction times describe how quickly we react to visual stimulus and convert these into actual movements. The Valkee bright light headset is a portable device that channels 8-12 minute doses of safe bright light directly to light-sensitive areas of the brain via the ear canal. Earlier in 2011, University of Oulu, Finland, presented two clinical trials using bright light via ear canals to treat seasonal affective disorder, and the presence of light-sensitive cells in the human brain.

Docent Mikko Tulppo, who led the study at the Department of Exercise and Medical Physiology at Verve Research, Finland, commented: "The placebo-controlled study showed a significant improvement in motoric reaction times of top athletes using bright light via the ear canal."  

Juuso Nissilä, chief scientist at Valkee, the inventor of the bright light headset, said: "The ice hockey players were all in prime cognitive and physical condition, and their reaction times were already extremely fast already before using the Valkee bright light headset. The fact that bright light via ear canals is proving to provide an additional edge is very promising for athletes and sports enthusiasts."

This placebo-controlled, phycho-motoric study of Valkee bright light via ear canal on national level ice hockey players in Finland was conducted independently by the Department of Exercise and Medical Physiology at Verve Research in the fall 2011.

Valkee launched its bright-light headset in August 2010. Being based on cross-functional science in neurology, biology, psychiatry and physiology, Valkee is a CE-certified Class II(a) medical device under the EU regulations.


About Valkee

The Valkee (http://valkee.com) bright light headset channels bright light direct to light-sensitive areas of the human brain via ear canals to improve mood and performance. In earlier clinical trials, 9 of 10 patients suffering from severe seasonal affective disorder - also known as winter blues - experienced total symptom relief latest in 4 weeks with a daily 8-12 minute dose. Valkee is based on scientific research carried out since 2007, and is a CE-marked Class II(a) medical device. More information and for international online shop http://valkee.com

About Department of Exercise and Medical Physiology at Verve

Verve is a Finnish nationwide provider of research, rehabilitation and consulting services for occupational health, and physiology and exercise research. The Department of Exercise and Medical Physiology at verve engages in cross-disciplinary research, which most significantly integrates exercise physiology, cardiology and mathematics. Verve's research team is especially interested in the interrelationships of cardiac function, exercise, stress and cognitive performance.



'/>"/>
SOURCE Valkee
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waterproof Keyboard Now Has Brighter, More Efficient Backlighting
2. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
3. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. 2011 China-Africa Brightness Action Launched in Beijing
6. Sanare Launches BrightSky, a New Consumer Brand Serving People Living With Diabetes
7. Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association
8. NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capitals Bright Lights Conference in New York City on May 10, 2011
9. Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011
10. BrightLife Direct Introduces 3 New Lymphedema Product Lines
11. Alexza to Present at the MDB Bright Lights Conference 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017   Divoti USA ... Jewelry up to the standard of the latest FDA requirements, which ... 2017). Anyone in need of Medical ID jewelry such ... Alert Jewelry are engraved in terms of the new ... Divoti offers ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
Breaking Medicine Technology:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):